Immune design corp. (IMDZ)
CashFlow / TTM
Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities
Net loss

-54,758

-53,137

-52,504

-52,542

-51,862

-54,328

-53,355

-53,856

-53,530

-51,199

-46,163

-42,333

-39,445

-40,450

-39,725

-35,334

-34,151

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

346

363

368

356

351

332

322

307

304

294

283

267

243

238

227

229

238

0

0

0

Amortization of premium/discount on investments

561

502

374

202

26

-201

-210

-200

-126

30

28

48

0

0

0

0

-

-

-

-

Stock-based compensation

7,276

8,084

8,430

9,124

8,633

8,977

9,154

9,195

9,283

8,753

7,834

7,401

6,297

4,917

3,934

2,388

1,344

0

0

0

Revaluation of convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,277

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

58

260

165

-263

130

-6,974

118

590

-455

4,351

-502

-1,565

-998

3,093

-159

1,566

1,883

0

0

0

Inventory

652

746

276

98

77

-101

-100

-129

594

402

290

678

-12

-174

415

13

8

0

0

0

Prepaid expenses

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-537

457

454

0

0

0

Other assets

-1,348

-2,870

-35

-49

-22

3,016

26

49

3,059

0

0

0

-

-

-

-

-

-

-

-

Accounts payable

-856

267

-1,090

-684

-2,225

-1,799

718

1,549

1,485

1,672

1,512

-658

-3,829

-391

761

1,486

6,037

0

0

0

Accrued liabilities

1,181

135

-1,024

-490

1,203

885

-1,380

35

976

775

3,493

2,221

-519

1,104

2,467

732

3,424

0

0

0

Accrued litigation-related settlement

-6,000

-7,250

-7,250

-7,250

-1,250

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and other noncurrent liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

500

507

0

0

0

Deferred rent and other liabilities

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Security deposits

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-35,000

-37,801

-38,143

-31,428

-30,469

-20,669

0

0

0

Investing activities
Purchases of property and equipment

390

353

410

430

428

401

340

316

133

195

275

314

427

461

433

417

344

0

0

0

Maturities of short-term investments

86,000

74,000

79,000

77,000

65,000

67,000

62,000

49,000

40,000

0

0

0

-

-

-

-

-

-

-

-

Purchases of short-term investments

-

0

0

73,533

-

0

0

65,287

-

65,000

48,000

46,000

0

0

0

0

-

-

-

-

Net cash provided by investing activities

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-46,314

-427

-461

-433

-417

-344

0

0

0

Financing activities
Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

Proceeds from issuances of common stock under stock-based compensation plans

228

388

674

654

714

701

440

430

144

219

388

359

436

0

0

0

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

75,846

75,795

75,706

142,856

66,100

65,980

0

0

0

Net cash provided by financing activities

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net (decrease) increase in cash and cash equivalents

-513

34,166

32,119

38,254

33,440

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow information
Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-50,056

-78,467

-5,468

37,567

37,102

110,995

35,214

44,967

0

0

0

Stock offering costs incurred, not yet paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0